Seagen Inc. Cashflow Statement

Ask AI

Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated Statements of Cash Flows

In millions of USD, except per-share amounts

	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021	FY2020 12 months to Dec 31, 2020	FY2019 12 months to Dec 31, 2019	FY2018 12 months to Dec 31, 2018
Operating activities:
Net (loss) income
Adjustments to reconcile net (loss) income to net cash (used) provided by operating activities
Share-based compensation
Depreciation and amortization
Amortization of intangible assets
Amortization of right-of-use-assets
Amortization of premiums, accretion of discounts, and (gains) losses on debt securities
Loss (gain) on equity securities
Gain on disposals of property and equipment
Income tax benefit on unrealized loss on available-for-sale securities
Other long-term liabilities
Deferred income taxes
Changes in operating assets and liabilities:
Accounts receivable, net
Inventories
Prepaid expenses and other assets
Accounts payable and accrued liabilities
Lease liabilities
Deferred revenue
Other liabilities

Net cash (used) provided by operating activities
Investing activities:
Purchases of securities
Proceeds from maturities of securities
Proceeds from sales of securities
Payments for lessor-owned assets
Purchases of property and equipment
Acquisition of manufacturing facility
Acquisition of Cascadian Therapeutics, Inc., net of cash acquired
Net cash provided (used) by investing activities

Financing activities:
Net proceeds from issuance of common stock
Proceeds from exercise of stock options and employee stock purchase plan
Net cash provided by financing activities
Net increase (decrease) in cash and cash equivalents
Cash and cash equivalents at end of year
Effect of exchange rate changes on cash, cash equivalents, and restricted cash
Net (decrease) increase in cash, cash equivalents, and restricted cash
Cash, cash equivalents, and restricted cash at beginning of year
Cash, cash equivalents, and restricted cash at end of year

Comments